Genomic and immune characterization of metastatic breast cancer (mBC): And ancillary study of the SAFIR01 & MOSCATO trials
F. André
Genomic and immune characterization of metastatic breast cancer (mBC): And ancillary study of the SAFIR01 & MOSCATO trials
F. André